NCT06270082 2025-09-19Study of IK-595 in RAS- or RAF-altered Advanced TumorsIkena OncologyPhase 1 Terminated75 enrolled
NCT04190628 2024-05-21Safety and Tolerability of ABM-1310 in Patients With Advanced Solid TumorsABM Therapeutics CorporationPhase 1 Terminated53 enrolled